Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Sirna Therapeutics
A biotechnology company utilising RNA interference in human disease therapy
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 13 Dec, 2023
"NL fact extraction"
Golden Au
edited on 13 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Number of Employees (Ranges)
51 – 200
0
Edits on 5 May, 2023
"Covert AngelList URL to Wellfound ID"
Golden AI
edited on 5 May, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Wellfound ID
sirna-therapeutics
Edits on 16 Mar, 2023
"prospector:2473:2557799"
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Biotechnology
"prospector:2472:2537659"
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Biology
Edits on 22 Feb, 2023
"prospector:2317:2477123"
Katrina-Kay Pettitt
edited on 22 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Technology
Edits on 27 Jul, 2022
"remove blacklisted domain URLs"
Golden AI
edited on 27 Jul, 2022
Infobox
Investors
Venrock
0
Edits on 18 Jul, 2022
"update inverses"
Golden AI
edited on 18 Jul, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Investors
Venrock
0
Edits on 25 May, 2022
"Edit from table cell"
Ольга Дрокина
edited on 25 May, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Company Operating Status
Active
Edits on 17 May, 2022
"prospector:1525:754881"
Katrina-Kay Pettitt
edited on 17 May, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
Tim D
edited on 16 May, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Crunchbase
https://www.crunchbase.com/organization/sirna-therapeutics
Edits on 8 Apr, 2022
"Patent autocalculation"
Golden AI
edited on 8 Apr, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents assigned (count)
38
Edits on 1 Mar, 2022
"Merge infobox in utils"
Golden AI
edited on 1 Mar, 2022
Edits made to:
Infobox
(
+1
/
-1
properties)
Infobox
Parent organization
Parent organization
Merck
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-35
properties)
Infobox
Patents
US Patent 7404969 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US Patent 7491805 Conjugates and compositions for cellular delivery
US Patent 7514099 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US Patent 7517864 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7521184 Detection and quantitation of nucleic acid molecules in biological samples
US Patent 7553830 Compositions for the delivery of negatively charged molecules
US Patent 7641915 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US Patent 7655790 Deprotection and purification of oligonucleotides and their derivatives
US Patent 7659389 RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
US Patent 7659390 RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7662951 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
US Patent 7662952 RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)
US Patent 7667029 RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
US Patent 7667030 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
US Patent 7678897 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
US Patent 7683165 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7683166 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7691405 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US Patent 7691999 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7700760 RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
US Patent 7777023 Method for the chemical synthesis of oligonucleotides
US Patent 7795422 RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
US Patent 7855284 RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
US Patent 7858625 Conjugates and compositions for cellular delivery
US Patent 7858769 RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA)
US Patent 7893248 RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
US Patent 7893249 Deprotection and purification of oligonucleotides and their derivatives
US Patent 7897752 RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
US Patent 7897753 RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
US Patent 7897755 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
US Patent 7910724 RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
US Patent 7910725 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7923547 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US Patent 7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US Patent 7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7923547 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7910725 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7910724 RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7897755 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 7897753 RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
Load more
Find more companies like Sirna Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE